Radiation Oncology/Therapy: Page 190

ASTRO awards Gold Medal to ViewRay CMO
By AuntMinnie.com staff writers
Image-guided therapy developer ViewRay said that the American Society for Radiation Oncology (ASTRO) will present its Gold Medal to the company's chief medical officer (CMO), Dr. Prabhakar Tripuraneni.
May 29, 2013
Mevion delivers accelerator
By AuntMinnie.com staff writers
Proton therapy developer Mevion Medical Systems has delivered a superconducting synchrocyclotron accelerator to the University of Oklahoma.
May 29, 2013
ASTRO: NIH underfunds radiation oncology research
By AuntMinnie.com staff writers
Radiation oncology research is gravely underfunded by the U.S. National Institutes of Health (NIH), according to the American Society for Radiation Oncology (ASTRO).
May 28, 2013
Study: Data for radiation therapy insufficient
By AuntMinnie.com staff writers
There is not enough randomized clinical trial data to provide doctors with sufficient evidence for radiation oncology treatment decisions, according to a study published online May 14 in the journal Cancer.
May 28, 2013
ROI requests radiation therapy research proposals
By AuntMinnie.com staff writers
The Radiation Oncology Institute (ROI) announced it is requesting proposals to examine the comparative value of radiation therapy.
May 27, 2013
Nordion to sell targeted therapies business to BTG
By AuntMinnie.com staff writers
Nordion has entered into an agreement to divest its targeted therapies business to BTG, an international healthcare company based in London, for $200 million U.S. (154 million euros) in cash.
May 22, 2013
Accuray touts CyberKnife study
By AuntMinnie.com staff writers
Radiation oncology firm Accuray said that a large study using its CyberKnife robotic radiosurgery system validated use of the technology for prostate cancer treatment.
May 21, 2013
Elekta installs radiotherapy system in Puerto Rico
By AuntMinnie.com staff writers
Caribbean Imaging and Radiation Treatment Center in Ponce, Puerto Rico, has acquired a Versa HD radiotherapy system from Elekta, the first to be installed in the U.S. territory, according to the firm.
May 16, 2013
FDA clears Bayer's Xofigo
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration has cleared the use of radium-223 dichloride to treat patients who have castration-resistant prostate cancer with symptomatic bone metastases and no known visceral metastatic disease.
May 15, 2013
Bard pays $48.2M in whistleblower lawsuit
By AuntMinnie.com staff writers
Interventional device developer C. R. Bard has agreed to pay the U.S. government $48.2 million to settle a whistleblower lawsuit alleging that its urological division and ProSeed subsidiary paid doctors and hospitals kickbacks to entice them to order Bard's products at inflated prices to treat Medicare patients with prostate cancer.
May 15, 2013
Health Affairs: Cancer patients face higher bankruptcy risk
By Cynthia E. Keen
Individuals diagnosed with cancer are at least 2.5 times more likely to declare bankruptcy than those without cancer, according to a study of patients in Washington state published online May 15 in Health Affairs.
May 14, 2013
Philips, Elekta add to MR-guided radiotherapy consortium
By AuntMinnie.com staff writers
Toronto's Sunnybrook Health Sciences Centre will join a consortium sponsored by Royal Philips Electronics and radiation oncology firm Elekta to validate the clinical potential of MRI-guided radiation therapy.
May 12, 2013
Previous Page
Page 190 of 468
Next Page